Skip to main content
Premium Trial:

Request an Annual Quote

MDS Reports 5-Percent Organic Growth in Analytics Revenue

NEW YORK (GenomeWeb News) — MDS today reported that second-quarter revenue for its MDS Analytical Technologies segment, which now includes MDS Sciex and Molecular Devices, increased 54 percent, although organic growth was 5 percent.
Total revenue for the three months ended March 31 increased to $88 million from $57 million. The majority of the increase came from recently acquired Molecular Devices, which MDS bought in March for $615 million. The company also recorded $3 million in expenses from the acquisition.  
R&D spending increased to $7 million from $1 million year over year.  
MDS said its services revenue drove growth and profitability.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.